Changeflow GovPing Healthcare & Life Sciences fMRI Study, BPD Adolescents, Quebec: Feasibilit...
Routine Notice Added Final

fMRI Study, BPD Adolescents, Quebec: Feasibility Study NCT07540429

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH ClinicalTrials.gov registered a new feasibility study (NCT07540429) investigating impaired social cognition and cognitive control associated with borderline personality disorder (BPD) in adolescents using functional magnetic resonance imaging (fMRI). The Franco-Canadian study is conducted in Quebec and includes participants with BPD, ADHD, and healthy controls. The study aims to explore neural correlates of BPD and related clinical disorders.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 725 changes logged to date.

What changed

NIH ClinicalTrials.gov added a new study registration (NCT07540429) for a feasibility study examining the use of functional magnetic resonance imaging (fMRI) in adolescents with borderline personality disorder. The study, conducted in Quebec, will recruit participants across three groups: BPD, ADHD, and healthy controls, and is based on a prior Franco-Canadian neuroimaging study.\n\nHealthcare providers, clinical investigators, and institutional review boards involved in adolescent mental health or neuroimaging research should note this registry entry for awareness. The registration provides transparency into ongoing clinical research but does not itself create compliance obligations for the regulated community.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

ADOLESCENTS IMAGING USING fMRI: Feasibility Study

N/A NCT07540429 Kind: NA Apr 20, 2026

Abstract

Impaired social cognition and cognitive control associated with borderline personality disorder (BPD) remain less explored. Recent Franco-Canadian study, has shown the feasibility of a neuroimaging tests in Quebec adolescents with BPD. This study aims to increase knowledgements related to neural correlates of BPD and clinical disorders.

Conditions: Diagnosis of BPD Based on the DIB-R Clinical Interview for the BPD Group, Diagnosis of ADHD Using the KSADS-PL for the ADHD Group, Absence of Pathology on the CBCL and Ab-DIB for the Healthy Control Group, All Participants Were Euthymic at the Time of Task Administration

Interventions: functional magnetic resonance imaging (fMRI)

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 20th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Neuroimaging research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!